Gi Innovation, Inc.

This study is testing the safety and effectiveness of a new investigational drug called GI-101 for people with advanced or metastatic solid tumors. The drug is designed to work in two ways to help the immune system fight cancer. Researchers will test it alone and in combination w…

This early-stage study is testing a new drug called GI-108 in people with advanced or spreading solid tumors, including lung, head and neck, pancreatic, and kidney cancers. The main goals are to find a safe dose and see if the drug shows any signs of helping to shrink tumors. The…

This study is testing whether a combination of an investigational drug (GI-102) and a probiotic blend (GIB-7) can improve certain biological signs of aging. It will involve about 15 healthy adults and cancer survivors, who will take the combination for 8 weeks. Researchers will m…